Buy Inbec Tablet Online: Price, Uses, and Side Effects

Uses

Treatment of HIV infection

Side Effects

The human body reacts differently to the Inbec tablet. Response or undesired symptoms vary from individual to individual. Usually, they disappear with time as the body adjusts to the medicine; these side effects don't need special medical attention. Whereas if the symptoms don't disappear with time or you have severe side effects, then consult your doctor immediately.

Some of the common side effects of Inbec tablet are mentioned below:

Headache
Blood in urine
Skin rash
Itching
Vomiting
Nausea
Diarrhea
Dizziness
Drowsiness
Hair loss
Fatigue

How To Use

Take the dose of Inbec tablet as per your healthcare provider’s prescription. Do not stop taking the medicine suddenly, unless your doctor tells you. This medicine is given under the strict supervision of a doctor. Do not self-administer.

Overdose is a very unusual state for this medicine because it is given under the supervision of a healthcare provider. Inbec tablet can be taken without food or with food. The doctor will provide emergency medical treatment. You should not break, crush, or chew the medicine; it should be swallowed as a whole.

How It Works

Inbec tablet contains Indinavir, which is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). These inhibitors block the part of HIV called protease.
HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1.
Indinavir works to bind to the protease active site and inhibits the activity of the enzyme. Further, this inhibition prevents cleavage of the viral polyproteins, resulting in the formation of an immature non-infectious viral particle.

Safety Advice

Alcohol

The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking the Inbec tablet. Consult your doctor for further information.

Pregnancy

The Inbec tablet may be considered unsafe during pregnancy. Please consult your doctor in such a condition. According to some research data, taking the Inbec tablet during pregnancy has shown harmful effects on the developing baby.

Breast Feeding

The Inbec tablet is probably not safe if you're breastfeeding. Kindly consult your doctor before taking the Inbec tablet while breastfeeding, as there are chances that it may pass to the developing baby through the breast milk of the mother.

Driving

It is advisable not to drive or operate heavy machinery after taking the Inbec tablet, as you may feel dizzy.

Kidney

Share your medical history with your healthcare expert in case of kidney disease before taking the Inbec tablet. Patients with renal impairment must be careful while taking the Inbec tablet. They may require adjustment in the dose.

Liver

Inform your doctor before starting the Inbec tablet if you have liver disease to avoid any serious side effects. Patients with hepatic impairment must be careful while taking the Inbec tablet. They may require adjustment in the dose.

Missed Doses

It is advisable to not skip a dose. If you miss a dose, make sure to take it as soon as you remember. However, if it is already time for your next scheduled dose, skip the missed dose and take the scheduled dose. Also, make sure to not increase the dose strength to catch up with the missed dose.

FAQs

What is Inbec (Indinavir) capsule used for?

Inbec (Indinavir) capsule is a prescription medicine, used in the treatment of HIV (Human Immunodeficiency Virus) infection. It interferes with an enzyme (protease), which is required by HIV-infected cells to make new viruses.

What are the possible side effects of Inbec (Indinavir) capsules?

The common side effects of Inbec (Indinavir) capsules are headache, nausea, taste change, stomach ache, peripheral neuropathy, diarrhea, fever, chills, hair loss, urine infection, kidney failure, etc. Make sure to contact your doctor if side effects occur or last longer than usual.

What is the storage condition for Inbec (Indinavir) capsules?

Store Inbec (Indinavir) capsules at room temperature (10-30°C) in the same container. Keep it away from children and pets.

What should I avoid while consuming Inbec (Indinavir) capsule?

Limit your sugar and salt intake because HIV may increase your chance of getting heart disease.

In what strength is Inbec (Indinavir) capsule available?

Inbec (Indinavir) capsule is available in the strength of 400 mg.

Does Inbec tablet affect memory?

Memory impairments have been reported in a few patients. Consult your doctor if you face problems with concentration, loss of memory, or are confused after taking Lenalidomide 10 mg capsules.

At what time should you take the Inbec tablet for its maximum benefit?

Time and dose are decided by your doctor. Inbec tablet should be taken at the same time, usually with a meal and a large glass of water to avoid stomach problems.

Can Lenalidomide 10 mg capsules be given to children?

No, children below 18 years of age are not advised to take Inbec tablets, as they result in severe complications.

Trusted Medicines, Delivered Worldwide

At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.

Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.

Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.

We currently ship to:

Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!

Reference

Gazzard B, Moecklinghoff C, Hill A. (2025). New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom. Clinicoecon Outcomes Res. 4:193–200 - https://pubmed.ncbi.nlm.nih.gov/22888265/
Kaufmann D, Pantaleo G, Sudre P, Telenti A. (2024). CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet. 351(9104):723–4 - https://pubmed.ncbi.nlm.nih.gov/9504519/
Montaner JS, Reiss P, Cooper D, Vella S, Harris M, Conway B, Wainberg MA, Smith D, Robinson P, Hall D, et al. (2024). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS trial. Italy, the Netherlands, Canada and Australia study. JAMA. 279(12):930–7.
Olalla J, Pérez-Stachowski J, Tortajada B, Del Arco A, Márquez E, De la Torre J, Nieto M, García de Lomas JM, Prada JL, García-Alegría J. (2025). Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks. BMC Pharmacol Toxicol.19(1):63 - https://pubmed.ncbi.nlm.nih.gov/31272264/
Pérez-Stachowski J, Tortajada B, Del Arco A, Márquez E, De la Torre J, Nieto M, García de Lomas JM, Prada JL, García-Alegría J, Olalla J. (2025). Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks. Infect Dis (Lond). 51(9):691-693 - https://pubmed.ncbi.nlm.nih.gov/31272264/
Walmsley S, Baumgarten A, Berenguer J, Felizarta F, Florence E, Khuong-Josses MA, Kilby JM, Lutz T, Podzamczer D, Portilla J, Roth N, Wong D, Granier C, Wynne B, Pappa K. (2025). Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial. J Acquir Immune Defic Syndr. 70(5):515-9 - https://pubmed.ncbi.nlm.nih.gov/26262777/

Inbec Tablet

Inbec Tablet

About The Product

Share & print

Scan or print QR code

Scan or print QR code

Uses

Ritesh Pandey

Andrew Taylor

Anjali Agarwal

Stay Healthy with magicine pharma: Your Favourite Online Pharmacy and Healthcare Platform

magicine pharma: Your Favourite Online Pharmacy!

The Feathers in Our Cap

The Services We Offer

Our Testimonials

Dr. Priya Sharma

Rajesh Kumar

Dr. Anjali Mehta

Vikram Singh

Neha Patel

Dr. Ravi Verma

Kavita Reddy

Amit Gupta

Dr. Shreya Joshi